publicações selecionadas
- What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
- Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?
- Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study
- Urticária crônica espontânea nos adultos: diagnóstico e terapêutica no presente e futuro. Uma revisão narrativa
- aaa
- Allergic Contact Dermatitis by Opthalmological Medications in Brazil: Experience of a Dermatology Department
- Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
- Potential interactions of SARS-CoV-2 with human cell receptors in the skin: understanding the enigma for a lower frequency of skin lesions compared to other tissues
- Dupilumab as useful treatment option for Prurigo Nodularis in an elderly patient with atopic dermatitis
- Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis - Part II
- Chronic Spontaneous Urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab
- Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I
-
What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during
COVID -19 or asymptomatic infections due toSARS-CoV -2? - M2 Macrophage Polarization in Chronic Spontaneous Urticaria Refractory to Antihistamine Treatment